Protara Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 11/14/2024 | 1.90 M | $3.48 M | 0.00% | 8.51% |
| OPALEYE MANAGEMENT INC. | 11/14/2024 | 1.68 M | $3.08 M | -27.04% | 7.53% |
| STEMPOINT CAPITAL LP | 11/13/2024 | 942,857 | $1.73 M | -4.19% | 4.22% |
| WOODLINE PARTNERS LP | 11/14/2024 | 851,567 | $1.56 M | 751.56% | 3.81% |
| BOXER CAPITAL, LLC | 11/14/2024 | 811,627 | $1.49 M | 0.00% | 3.63% |
| VANGUARD GROUP INC | 11/13/2024 | 759,612 | $1.39 M | 77.64% | 3.40% |
| CITADEL ADVISORS LLC | 11/14/2024 | 680,511 | $1.25 M | 2.28% | 3.05% |
| VELAN CAPITAL INVESTMENT MANAGEMENT LP | 11/14/2024 | 574,000 | $1.05 B | 19.58% | 2.57% |
| BAKER BROS. ADVISORS LP | 11/14/2024 | 536,832 | $982,403 | 0.00% | 2.40% |
| RENAISSANCE TECHNOLOGIES LLC | 11/13/2024 | 336,740 | $616,234 | 123.90% | 1.51% |
| TWO SIGMA INVESTMENTS, LP | 11/14/2024 | 185,223 | $338,958 | 18.91% | 0.83% |
| OPPENHEIMER & CO INC | 11/05/2024 | 179,125 | $327,799 | 40.84% | 0.80% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2024 | 170,040 | $311,201 | 21.00% | 0.76% |
| IKARIAN CAPITAL, LLC | 11/14/2024 | 155,712 | $284,953 | -13.83% | 0.70% |
| TWO SIGMA ADVISERS, LP | 11/14/2024 | 151,618 | $277,461 | 88.30% | 0.68% |
| BLACKROCK FUNDING, INC. /DE | 11/13/2024 | 116,977 | $214,068 | 100.00% | 0.52% |
| MARSHALL WACE, LLP | 11/14/2024 | 77,351 | $141,552 | 0.00% | 0.35% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 11/14/2024 | 49,200 | $90,036 | 103.31% | 0.22% |
| LPL FINANCIAL LLC | 11/08/2024 | 46,000 | $84,180 | 4.55% | 0.21% |
| TRUIST FINANCIAL CORP | 11/13/2024 | 40,000 | $73,200 | 100.00% | 0.18% |
| XTX TOPCO LTD | 11/14/2024 | 32,682 | $59,808 | 100.00% | 0.15% |
| CIBC WORLD MARKET INC. | 11/12/2024 | 28,000 | $51,000 | -24.32% | 0.13% |
| STATE STREET CORP | 11/14/2024 | 26,600 | $48,678 | 0.00% | 0.12% |
| COMMONWEALTH EQUITY SERVICES, LLC | 10/18/2024 | 19,428 | $36,000 | 0.00% | 0.09% |
| BANK OF NEW YORK MELLON CORP | 11/12/2024 | 17,907 | $32,769 | 0.00% | 0.08% |
| BOOTHBAY FUND MANAGEMENT, LLC | 11/14/2024 | 17,398 | $31,838 | -13.83% | 0.08% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2024 | 14,402 | $26,356 | 100.00% | 0.06% |
| CITADEL ADVISORS LLC | 11/14/2024 | 9,000 | $16,470 | 7.14% | 0.04% |
| UBS GROUP AG | 11/14/2024 | 7,418 | $13,575 | 100.00% | 0.03% |
| ROYAL BANK OF CANADA | 11/14/2024 | 3,500 | $6,000 | -44.46% | 0.02% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 11/14/2024 | 2,783 | $5,093 | -30.75% | 0.01% |
| CITADEL ADVISORS LLC | 11/14/2024 | 1,800 | $3,294 | 20.00% | 0.01% |
| SEMMAX FINANCIAL ADVISORS INC. | 11/14/2024 | 1,572 | $4,056 | 100.00% | 0.01% |
| BANK OF AMERICA CORP /DE/ | 11/14/2024 | 366 | $670 | 145.64% | 0.00% |
| ADVISOR GROUP HOLDINGS, INC. | 11/13/2024 | 100 | $183 | 0.00% | 0.00% |
| WELLS FARGO & COMPANY/MN | 11/13/2024 | 0 | $0 | -100.00% | 0.00% |
| WOLVERINE TRADING, LLC | 11/14/2024 | 0 | $0 | -100.00% | 0.00% |
| GROUP ONE TRADING, L.P. | 11/14/2024 | 0 | $0 | -100.00% | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2024 | 0 | $0 | -100.00% | 0.00% |
| JANE STREET GROUP, LLC | 11/15/2024 | 0 | $0 | -100.00% | 0.00% |
| ARMISTICE CAPITAL, LLC | 11/14/2024 | 0 | $0 | -100.00% | 0.00% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 11/14/2024 | 0 | $0 | -100.00% | 0.00% |
| PRIVIUM FUND MANAGEMENT (UK) LTD | 11/05/2024 | 0 | $0 | -100.00% | 0.00% |
Protara Therapeutics, Inc.institutional Ownership - FAQ's
During the previous two years, 44 institutional investors and hedge funds held shares of Protara Therapeutics, Inc.. The most heavily invested institutionals were:
RA CAPITAL MANAGEMENT, L.P.: 1.9 M
Opaleye Management Inc.: 1.68 M
StemPoint Capital LP: 942,857
Woodline Partners LP: 851,567
Boxer Capital, LLC: 811,627
VANGUARD GROUP INC: 759,612
46.79% of Protara Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 10.87 M shares in the last 24 months. This purchase volume represents approximately $56.21 M in transactions.